Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maltiron Plus
- Development stage
- Unknown
- Lead developer
- MEPROFARM
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Maltiron Plus is an oral multivitamin and mineral supplement developed and marketed by the Indonesian pharmaceutical company Meprofarm. It is formulated as a film-coated tablet containing essential vitamins (including Vitamin A, B-complex vitamins, Vitamin C, Vitamin D3, and Vitamin E) and minerals (such as ferrous fumarate, calcium carbonate, zinc sulfate, sodium fluoride, and potassium iodide). Maltiron Plus is primarily indicated for the prevention and treatment of vitamin and mineral deficiencies, particularly during pregnancy, lactation, chronic illness, and convalescence. It also helps address iron deficiency anemia by providing supplemental iron and folic acid to support red blood cell production.
- Brand names
- Maltiron Plus
- Other names
- Maltiron Plus Tablet
Beyond the preview
Go deeper on Maltiron Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Maltiron Plus.